Literature DB >> 11860190

The rate of Tau synthesis is differentially regulated during postnatal development in mouse cerebellum.

G J Vilá-Ortiz1, T A Santa-Coloma, H Carminatti, M Radrizzani.   

Abstract

1. Tau, which is a microtubule-associated protein, with mRNA targeted to the axon and growth cone, is involved in axonal elongation. During postnatal development in mouse, Tau expression in cerebellar granule cells is reduced afte the second postnatal week. The aim of this work was to study the regulation of the rate of the synthesis of Tau protein during the period of granule cell axonal growth in mouse cerebellum. 2. We found four [35S]methionine-labeled isoforms of Tau synthesized postnataly. Their levels remain constant from postnatal day 9 to 12 (P9-P12), and decreased by P20. 3. The rate of Tau synthesis showed differences with the rate of synthesis of total proteins. They also differ from proteins phosphatases 2A and 2B, both associated with the regulation of Tau function. In addition, the turnover of newly synthesized Tau increased at P20, compared with P9 and P12. 4. These results imply a specific developmental regulation of mRNA translation of Tau, and indicate that, after the period of synapse formation is complete, and therefore axonal growth has finished (P20), only a limited number of new Tau molecules are synthesized. This might reflect that, after synapse formation is complete, newly synthesized Tau molecules are not longer needed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11860190     DOI: 10.1023/a:1013823524302

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  23 in total

1.  Differential expression of CPD1 during postnatal development in the mouse cerebellum.

Authors:  M Radrizzani; G Vilá-Ortiz; E G Cafferata; M C Di Tella; A González-Guerrico; C Perandones; O H Pivetta; H Carminatti; V P Idoyaga Vargas; T A Santa-Coloma
Journal:  Brain Res       Date:  2001-07-13       Impact factor: 3.252

2.  Heterogeneity of Tau proteins during mouse brain development and differentiation of cultured neurons.

Authors:  J C Larcher; D Boucher; I Ginzburg; F Gros; P Denoulet
Journal:  Dev Biol       Date:  1992-11       Impact factor: 3.582

3.  Expression of Tau protein and Tau mRNA in the cerebellum during axonal outgrowth.

Authors:  D Couchie; F Legay; J Guilleminot; F Lebargy; J P Brion; J Nunez
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

4.  The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons.

Authors:  A Caceres; S Potrebic; K S Kosik
Journal:  J Neurosci       Date:  1991-06       Impact factor: 6.167

Review 5.  Genes involved in cerebellar cell specification and differentiation.

Authors:  M E Hatten; J Alder; K Zimmerman; N Heintz
Journal:  Curr Opin Neurobiol       Date:  1997-02       Impact factor: 6.627

6.  Altered microtubule organization in small-calibre axons of mice lacking tau protein.

Authors:  A Harada; K Oguchi; S Okabe; J Kuno; S Terada; T Ohshima; R Sato-Yoshitake; Y Takei; T Noda; N Hirokawa
Journal:  Nature       Date:  1994-06-09       Impact factor: 49.962

7.  Calcineurin is associated with the cytoskeleton of cultured neurons and has a role in the acquisition of polarity.

Authors:  A Ferreira; R Kincaid; K S Kosik
Journal:  Mol Biol Cell       Date:  1993-12       Impact factor: 4.138

8.  Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.

Authors:  E Sontag; V Nunbhakdi-Craig; G Lee; R Brandt; C Kamibayashi; J Kuret; C L White; M C Mumby; G S Bloom
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

9.  The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases.

Authors:  M Mawal-Dewan; J Henley; A Van de Voorde; J Q Trojanowski; V M Lee
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

10.  Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes.

Authors:  Y Takei; J Teng; A Harada; N Hirokawa
Journal:  J Cell Biol       Date:  2000-09-04       Impact factor: 10.539

View more
  3 in total

Review 1.  Human fetal tau protein isoform: possibilities for Alzheimer's disease treatment.

Authors:  Nataša Jovanov-Milošević; Davor Petrović; Goran Sedmak; Mario Vukšić; Patrick R Hof; Goran Simić
Journal:  Int J Biochem Cell Biol       Date:  2012-05-15       Impact factor: 5.085

2.  Increased dendritic spine density and tau expression are associated with individual differences in steroidal regulation of male sexual behavior.

Authors:  Pranay Bharadwaj; Christine McInnis; Amanda M K Madden; Paul J Bonthuis; Susan Zup; Emilie F Rissman; Jin Ho Park
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

3.  No change in plasma tau and serum neurofilament light concentrations in adolescent athletes following sport-related concussion.

Authors:  Colin Wallace; Henrik Zetterberg; Kaj Blennow; Paul van Donkelaar
Journal:  PLoS One       Date:  2018-10-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.